Dr. Steven E Kanarek , MD
Internal Medicine - Cardiovascular Disease • Hackensack, NJ
920 Main St
Hackensack, NJ 076015017
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Steven Kanarek is listed in NPPES under Internal Medicine - Cardiovascular Disease.
-
NPI assigned on March 2, 2007; this date does not establish years in practice.
-
Published CMS data list 3,566 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 731 service units.
- 93000 — Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report: 575 service units.
- 93306 — Ultrasound of heart with color-depicted blood flow, rate, direction and valve function: 538 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 15 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 7,378 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium — 1,048 prescription fills, including refills.
- Ezetimibe — 859 prescription fills, including refills.
- Amlodipine Besylate — 672 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 55 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Cardiovascular Disease in Hackensack, NJ (2024, 20 clinicians with data). Median for this group: 2,104. Middle half: 492 to 3,591.
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Cardiovascular Disease in New Jersey (2024, 815 clinicians with data). Median for this group: 2,802. Middle half: 1,534 to 4,234.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,716 in 2020 to 3,566 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
920 Main St
Hackensack, NJ 076015017
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Hackensack Meridian Health Medical Group - Specialty Care Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Albert Einstein College Of Medicine Of Yeshiva University
1996
What Public CMS Data Show
Internal Medicine - Cardiovascular Disease: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,540 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $249,501 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $184,466 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
20,989 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$927,759 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $591.99 across 40 records.
By nature of payment
- Food and Beverage: $591.99 across 40 records.
Reporting-company totals (3 largest of 12)
- Novartis Pharmaceuticals Corporation: $165.46 across 16 records.
- Boehringer Ingelheim Pharmaceuticals, Inc.: $75.82 across 5 records.
- Alnylam Pharmaceuticals Inc.: $53.16 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
30 years (graduated 1996)
CMS Doctors and Clinicians data list 1996 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Kanarek has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Kanarek as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Hackensack and New Jersey
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 70% of clinicians listed under Internal Medicine - Cardiovascular Disease in Hackensack, NJ (2024, 20 clinicians with data). Median for this group: 2,104. Middle half: 492 to 3,591.
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Cardiovascular Disease in New Jersey (2024, 815 clinicians with data). Median for this group: 2,802. Middle half: 1,534 to 4,234.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine - Cardiovascular Disease in Hackensack, NJ (2024, 20 clinicians with data). Median for this group: $165,515. Middle half: $56,363 to $367,952.
Close to the middle for clinicians listed under Internal Medicine - Cardiovascular Disease in New Jersey (2024, 815 clinicians with data). Median for this group: $233,630. Middle half: $125,699 to $363,594.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine - Cardiovascular Disease in Hackensack, NJ (2024, 20 clinicians with data). Median for this group: $127,419. Middle half: $42,944 to $290,283.
Close to the middle for clinicians listed under Internal Medicine - Cardiovascular Disease in New Jersey (2024, 815 clinicians with data). Median for this group: $176,992. Middle half: $92,307 to $272,795.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Internal Medicine - Cardiovascular Disease in Hackensack, NJ (2024, 15 clinicians with data). Median for this group: 2,118. Middle half: 846 to 5,759.
More Part D prescriptions than 85% of clinicians listed under Internal Medicine - Cardiovascular Disease in New Jersey (2024, 827 clinicians with data). Median for this group: 3,115. Middle half: 1,145 to 5,444.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Cardiovascular Disease in Hackensack, NJ (2024, 15 clinicians with data). Median for this group: $249,115. Middle half: $150,345 to $640,927.
A higher Part D drug cost than 70% of clinicians listed under Internal Medicine - Cardiovascular Disease in New Jersey (2024, 827 clinicians with data). Median for this group: $534,339. Middle half: $183,348 to $991,647.
23 active clinicians are listed under Internal Medicine - Cardiovascular Disease with a practice address in Hackensack, NJ (1,104 in New Jersey).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Hackensack
21.7% of these 23 clinicians have the CMS telehealth indicator.
82.6% of these 23 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 31% from 2,716 in 2020 to 3,566 in 2024.
- 2020: 2,716
- 2021: 3,349
- 2022: 3,276
- 2023: 4,024
- 2024: 3,566
-
Medicare-allowed amount
Medicare-allowed amount increased 26% from $198,570 in 2020 to $249,501 in 2024.
- 2020: $198,570
- 2021: $265,935
- 2022: $252,513
- 2023: $278,797
- 2024: $249,501
-
Paid by Medicare
Paid by Medicare increased 24% from $148,821 in 2020 to $184,466 in 2024.
- 2020: $148,821
- 2021: $199,128
- 2022: $185,626
- 2023: $209,131
- 2024: $184,466
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 40% from 5,253 in 2020 to 7,378 in 2024.
- 2020: 5,253
- 2021: 6,018
- 2022: 6,119
- 2023: 6,821
- 2024: 7,378
-
30-day fills
30-day fills increased 44% from 14,547 in 2020 to 20,989 in 2024.
- 2020: 14,547
- 2021: 16,902
- 2022: 17,358
- 2023: 19,416
- 2024: 20,989
-
Part D drug cost
Part D drug cost increased 76% from $528,036 in 2020 to $927,759 in 2024.
- 2020: $528,036
- 2021: $671,083
- 2022: $701,938
- 2023: $858,925
- 2024: $927,759
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $313.98 in 2021 to $591.99 in 2025.
- 2021: $313.98
- 2022: $367.53
- 2023: $275.39
- 2024: $318.37
- 2025: $591.99
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 40 records totaling $591.99.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.43 |
| Philips North America LLC |
Food and Beverage
Cash or cash equivalent
|
MCOT | General | $24.94 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $24.70 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
AVEIR | General | $22.62 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $20.49 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $20.00 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $18.62 |
| Alnylam Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
AMVUTTRA | General | $18.20 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $18.08 |
| Alnylam Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
AMVUTTRA | General | $18.06 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $17.92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $17.23 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $17.21 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $17.15 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
— | General | $16.93 |
| Alnylam Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
AMVUTTRA | General | $16.90 |
| Philips North America LLC |
Food and Beverage
Cash or cash equivalent
|
MCOT | General | $16.86 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $16.85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $16.82 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
VYNDAQEL | General | $16.56 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $16.39 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $16.10 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $15.98 |
| HEARTFLOW, INC. |
Food and Beverage
Cash or cash equivalent
|
FFRct | General | $15.96 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $15.02 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
731 | 435 | $300.40 | $103.82 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
575 | 508 | $50.00 | $16.46 |
|
93306
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
|
538 | 518 | $220.48 | $75.68 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
421 | 131 | $255.43 | $87.77 |
|
93010
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only
|
414 | 366 | $30.00 | $9.01 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
346 | 287 | $425.69 | $145.72 |
|
93356
Heart muscle strain imaging
|
146 | 134 | $125.96 | $12.73 |
|
93016
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician
|
75 | 75 | $70.00 | $23.21 |
|
93018
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician
|
75 | 75 | $45.67 | $15.33 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
69 | 69 | $550.72 | $190.28 |
|
93308
Ultrasound of heart, follow-up
|
58 | 56 | $84.83 | $27.03 |
|
78452
Nuclear medicine studies of heart muscle at rest and with stress and spect
|
54 | 54 | $241.85 | $83.17 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
32 | 29 | $381.56 | $132.00 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
20 | 20 | $557.25 | $192.36 |
|
93272
Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional
|
12 | 12 | $80.00 | $26.63 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 1,048 | 91,087 | $18,709.86 | 305 |
| Ezetimibe | Ezetimibe | 859 | 76,469 | $21,979.32 | 268 |
| Amlodipine Besylate | Amlodipine Besylate | 672 | 58,998 | $5,112.96 | 208 |
| Metoprolol Succinate | Metoprolol Succinate | 638 | 55,268 | $9,646.71 | 193 |
| Atorvastatin Calcium | Atorvastatin Calcium | 550 | 49,104 | $6,685.90 | 164 |
| Valsartan | Valsartan | 399 | 34,919 | $13,213.88 | 130 |
| Eliquis | Apixaban | 362 | 24,023 | $448,972.12 | 92 |
| Losartan Potassium | Losartan Potassium | 323 | 28,007 | $3,579.41 | 105 |
| Lisinopril | Lisinopril | 262 | 23,520 | $2,324.95 | 76 |
| Hydrochlorothiazide | Hydrochlorothiazide | 226 | 19,754 | $1,568.82 | 79 |
| Carvedilol | Carvedilol | 149 | 12,530 | $2,058.93 | 40 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 126 | 10,716 | $4,711.90 | 48 |
| Furosemide | Furosemide | 115 | 9,536 | $639.60 | 52 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 102 | 8,385 | $1,204.38 | 29 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 96 | 8,088 | $3,259.87 | 33 |
| Digoxin | Digoxin | 91 | 7,615 | $4,290.61 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 83 | 7,429 | $1,824.15 | 26 |
| Xarelto | Rivaroxaban | 82 | 5,646 | $102,906.08 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 80 | 7,004 | $1,471.83 | 26 |
| Labetalol Hcl | Labetalol Hcl | 75 | 6,153 | $2,984.56 | 26 |
| Atenolol | Atenolol | 70 | 6,235 | $587.56 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 52 | 4,511 | $1,204.77 | 20 |
| Entresto | Sacubitril/Valsartan | 52 | 3,680 | $78,627.75 | 15 |
| Warfarin Sodium | Warfarin Sodium | 51 | 4,590 | $523.84 | 11 |
| Jardiance | Empagliflozin | 49 | 3,330 | $62,483.56 | 16 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207RC0000X
An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - CARDIOVASCULAR DISEASE (CARDIOLOGY)
I20041014000012
NJ
5698735678
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Hackensack Meridian Health Medical Group - Specialty Care Pc
30 Prospect Ave, Hackensack, NJ 076011915
Phone: 5519965045
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated March 02, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine - Cardiovascular Diseases in Hackensack
- Dr. Sharon Maza, MD
- Dr. Michael Cohen, MD
- Dr. Rajiv Patel, DO
- Dr. Samuel Friedman, MD, FACC
- Dr. Sarah Timmapuri, MD, FACC
- Dr. Angel Mulkay, MD
Mailing Address
920 Main St
Hackensack, NJ 076015017
Phone: 2013427733